Liệu pháp quang động với nanomedicine thông minh

Abbas M, Zou Q, Li S, Yan X (2017) Self-assembled peptide-and protein-based nanomaterials for antitumor photodynamic and photothermal therapy. Adv Mater 29:1605021. https://doi.org/10.1002/adma.201605021 Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61:250–281. https://doi.org/10.3322/caac.20114 Barr H, Dix A, Kendall C, Stone N (2001) The potential role for photodynamic therapy in the management of upper gastrointestinal disease. Aliment Pharmacol Ther 15:311–321. https://doi.org/10.1046/j.1365-2036.2001.00936.x Baskaran R, Lee J, Yang S-G (2018) Clinical development of photodynamic agents and therapeutic applications. Biomater Res 22:1–8. https://doi.org/10.1186/s40824-018-0140-z Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, Pogue BW, Hasan T (2010) Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 110:2795–2838. https://doi.org/10.1021/cr900300p Chan W, Lam D, Lai T, Tam B, Liu D, Chan C (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453–1458. https://doi.org/10.1136/bjo.87.12.1453 Chang H-I, Yeh M-K (2012) Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed 7:49. https://doi.org/10.2147/IJN.S26766 Cheung CMG, Lai TY, Ruamviboonsuk P, Chen S-J, Chen Y, Freund KB, Gomi F, Koh AH, Lee W-K, Wong TY (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125:708–724. https://doi.org/10.1016/j.ophtha.2017.11.019 Choi JH, Lee YJ, Kim D (2017) Image-guided nanomedicine for cancer. J Pharm Investig 47:51–64. https://doi.org/10.1007/s40005-016-0297-1 Christie JG, Kompella UB (2008) Ophthalmic light sensitive nanocarrier systems. Drug Discov Today 13:124–134. https://doi.org/10.1016/j.drudis.2007.12.005 Daniell M, Hill J (1991) A history of photodynamic therapy. ANZ J Surg 61:340–348. https://doi.org/10.1111/j.1445-2197.1991.tb00230.x Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380. https://doi.org/10.1038/nrc1071 Fabian I, Stacey A, Papastefanou V, Al Harby L, Arora A, Sagoo M, Cohen V (2017) Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma. Eye 31:519. https://doi.org/10.1038/eye.2017.22 Finsen NR (1895) The red light treatment of small-pox. Br Med J 2:1412. https://doi.org/10.1136/bmj.2.1823.1412-a Guan M, Ge J, Wu J, Zhang G, Chen D, Zhang W, Zhang Y, Zou T, Zhen M, Wang C (2016) Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy. Biomaterials 103:75–85. https://doi.org/10.1016/j.biomaterials.2016.06.023 Han J, Hwang HS, Na K (2018) TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy. Biomaterials 182:259–268. https://doi.org/10.1016/j.biomaterials.2018.08.024 Ho Hong S, Choi Y (2018) Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents. J Pharm Investig 48:3–17. https://doi.org/10.1007/s40005-017-0356-2 Hwang HS, Shin H, Han J, Na K (2018) Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. J Pharm Investig 48:143–151. https://doi.org/10.1007/s40005-017-0377-x Incorvaia C, Campa C, Parmeggiani F, Menzione M, Dangelo S, Della Corte M, Rinaldi M, Romano M, Dellomo R, Costagliola C (2008) 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration. Retina 28:289–297. https://doi.org/10.1097/IAE.0b013e31813ffe90 Jeon G, Ko YT (2019) Enhanced photodyamic therapy via photosensitizer-loaded nanoparticles for cancer treatment. J Pharm Investig 49:1–8. https://doi.org/10.1007/s40005-017-0363-3 Jeong S, Lee J, Im BN, Park H, Na K (2017) Combined photodynamic and antibiotic therapy for skin disorder via lipase-sensitive liposomes with enhanced antimicrobial performance. Biomaterials 141:243–250. https://doi.org/10.1016/j.biomaterials.2017.07.009 Jo Y-U, Lee CB, Bae SK, Na K (2019) Acetylated hyaluronic acid-poly (L-lactic acid) conjugate nanoparticles for inhibition of doxorubicinol production from doxorubicin. Macromol Res 28:67–73. https://doi.org/10.1007/s13233-020-8003-6 Kelly J, Snell M (1976) Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 115:150–151. https://doi.org/10.1016/S0022-5347(17)59108-9 Kim J, Kim KS, Park SJ, Na K (2015) Vitamin Bc-bearing hydrophilic photosensitizer conjugate for photodynamic cancer theranostics. Macromol Biosci 15:1081–1090. https://doi.org/10.1002/mabi.201500060 Kim K, Lee C-S, Na K (2016) Light-controlled reactive oxygen species (ROS)-producible polymeric micelles with simultaneous drug-release triggering and endo/lysosomal escape. Chem Commun 52:2839–2842. https://doi.org/10.1039/C5CC09239F Kim DH, Hwang HS, Na K (2018a) Photoresponsive micelle-incorporated doxorubicin for chemo-photodynamic therapy to achieve synergistic antitumor effects. Biomacromol 19:3301–3310. https://doi.org/10.1021/acs.biomac.8b00607 Kim KS, Kim J, Kim DH, Hwang HS, Na K (2018b) Multifunctional trastuzumab–chlorin e6 conjugate for the treatment of HER2-positive human breast cancer. Biomater Sci 6:1217–1226. https://doi.org/10.1039/C7BM01084B Kim J, Park W, Kim D, Lee ES, Lee DH, Jeong S, Park JM, Na K (2019) Tumor-specific aptamer-conjugated polymeric photosensitizer for effective endo-laparoscopic photodynamic therapy. Adv Funct Mater. https://doi.org/10.1002/adfm.201900084 Kliman GH, Puliafito CA, Stern D, Borirakchanyavat S, Gregory WA (1994) Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization. Lasers Surg Med 15:2–10. https://doi.org/10.1002/lsm.1900150103 Koh A, Lai TY, Takahashi K, Wong TY, Chen L-J, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH (2017) Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 135:1206–1213. https://doi.org/10.1001/jamaophthalmol.2017.4030 Lee C-S, Na K (2014) Photochemically triggered cytosolic drug delivery using pH-responsive hyaluronic acid nanoparticles for light-induced cancer therapy. Biomacromol 15:4228–4238. https://doi.org/10.1021/bm501258s Lee C-S, Park W, Park S-J, Na K (2013) Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption. Biomaterials 34:9227–9236. https://doi.org/10.1016/j.biomaterials.2013.08.037 Lee C-S, Park W, Jo YU, Na K (2014) A charge-switchable, four-armed polymeric photosensitizer for photodynamic cancer therapy. Chem Commun 50:4354–4357. https://doi.org/10.1039/C4CC00746H Lee JH, Lee SC, Kim H, Lee CS (2019) Comparison of short-term efficacy between oral spironolactone treatment and photodynamic therapy for the treatment of nonresolving central serous chorioretinopathy. Retina 39:127–133. https://doi.org/10.1097/IAE.0000000000001913 Li X, Kolemen S, Yoon J, Akkaya EU (2017) Activatable photosensitizers: agents for selective photodynamic therapy. Adv Funct Mater 27:1604053. https://doi.org/10.1002/adfm.201604053 Li X, Kwon N, Guo T, Liu Z, Yoon J (2018a) Innovative strategies for hypoxic-tumor photodynamic therapy. Angew Chem Int Ed Engl 57:11522–11531. https://doi.org/10.1002/anie.201805138 Li X, Lee D, Huang JD, Yoon J (2018b) Phthalocyanine-assembled nanodots as photosensitizers for highly efficient type I photoreactions in photodynamic therapy. Angew Chem Int Ed Engl 130:10033–10038. https://doi.org/10.1002/anie.201806551 Li X, Lee S, Yoon J (2018c) Supramolecular photosensitizers rejuvenate photodynamic therapy. Chem Soc Rev 47:1174–1188. https://doi.org/10.1039/C7CS00594F Lipson RL, Baldes EJ (1960) The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol 82:508–516. https://doi.org/10.1001/archderm.1960.01580040026005 Lipson RL, Baldes EJ, Olsen AM (1961) The use of a derivative of hematoporphyrin in tumor detection. J Natl Cancer Inst 26:1–11. https://doi.org/10.1093/jnci/26.1.1 Maisch T (2015) Resistance in antimicrobial photodynamic inactivation of bacteria. Photochem Photobiol Sci 14:1518–1526. https://doi.org/10.1039/C5PP00037H Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6:583. https://doi.org/10.1038/nrc1893 Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392:1147–1159. https://doi.org/10.1016/S0140-6736(18)31550-2 Mitri Z, Constantine T, Oregan R (2012) The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy. Chemother Res Pract 2012:743193. https://doi.org/10.1155/2012/743193 Park SJ, Park W, Na K (2015) Tumor intracellular-environment responsive materials shielded nano-complexes for highly efficient light-triggered gene delivery without cargo gene damage. Adv Funct Mater 25:3472–3482. https://doi.org/10.1002/adfm.201500737 Park H, Lee J, Jeong S, Im BN, Kim MK, Yang SG, Na K (2016a) Lipase-sensitive transfersomes based on photosensitizer/polymerizable lipid conjugate for selective antimicrobial photodynamic therapy of acne. Adv Healthcare Mater 5:3139–3147. https://doi.org/10.1002/adhm.201600815 Park W, Park S-J, Cho S, Shin H, Jung Y-S, Lee B, Na K, Kim D-H (2016b) Intermolecular structural change for thermoswitchable polymeric photosensitizer. J Am Chem Soc 138:10734–10737. https://doi.org/10.1021/jacs.6b04875 Pointdujour-Lim R, Mashayekhi A, Shields JA, Shields CL (2017) Photodynamic therapy for choroidal nevus with subfoveal fluid. Retina 37:718–723. https://doi.org/10.1097/IAE.0000000000001202 Raab O (1900) Uber die Wirkung fluorescirender Stoffe auf Infusorien. Z biol 39:524–546 Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67:177–193. https://doi.org/10.3322/caac.21395 Vera DMA, Haynes MH, Ball AR, Dai T, Astrakas C, Kelso MJ, Hamblin MR, Tegos GPJP (2012) Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes. Photochem Photobiol 88:499–511. https://doi.org/10.1111/j.1751-1097.2012.01087.x Wang M, Munch IC, Hasler PW, Prünte C, Larsen M (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145. https://doi.org/10.1111/j.1600-0420.2007.00889.x Youn YS, Kwag DS, Lee ES (2017) Multifunctional nano-sized fullerenes for advanced tumor therapy. J Pharm Investig 47:1–10. https://doi.org/10.1007/s40005-016-0282-8 Zhu H, Li J, Qi X, Chen P, Pu K (2017) Oxygenic hybrid semiconducting nanoparticles for enhanced photodynamic therapy. Nano Lett 18:586–594. https://doi.org/10.1021/acs.nanolett.7b04759 Zuluaga MF, Mailhos C, Robinson G, Shima DT, Gurny R, Lange N (2007) Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration. Invest Ophthalmol Vis Sci 48:1767–1772. https://doi.org/10.1167/iovs.06-1224